Screening for Colorectal Neoplasias with Fecal Occult Blood Tests: False-positive Impact of Non-Dietary Restriction

被引:9
作者
Roslani, April Camilla [1 ]
Abdullah, Taufiq [2 ]
Arumugam, Kulenthran [1 ]
机构
[1] Univ Malaya, Canc Res Inst, Kuala Lumpur, Malaysia
[2] Univ Malaya, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia
关键词
Colorectal cancer; fecal occult blood test; screening; diet restriction; CANCER STATISTICS; CONTROLLED TRIAL; COLONOSCOPY; POPULATION; SURVIVAL;
D O I
10.7314/APJCP.2012.13.1.237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Screening for colorectal cancer using guaiac-based fecal occult blood tests (gFOBT) is well established in Western populations, but is hampered by poor patient compliance due to the imposed dietary restrictions. Fecal immunochemical tests (FIT) do not require dietary restriction, but are more expensive than gFOBT and therefore restrict its use in developing countries in Asia. However, Asian diets being low in meat content may not require diet restriction for gFOBT to achieve equivalent results. The objective of this study was to evaluate and compare the validity and suitability of gFOBT and FIT or a combination of the two in screening for colorectal neoplasias without prior dietary restriction in an Asian population. Methods: Patients referred to the Endoscopic Unit for colonoscopy were recruited for the study. Stool samples were collected prior to bowel preparation, and tested for occult blood with both gFOBT and FIT. Dietary restriction was not imposed. To assess the validity of either tests or in combination to detect a neoplasm or cancer in the colon, their false positive rates, their sensitivity (true positive rate) and the specificity (true negative rate) were analyzed and compared. Results: One hundred and three patients were analysed. The sensitivity for picking up any neoplasia was 53% for FIT, 40% for gFOBT and 23.3% for the combination. The sensitivities for picking up only carcinoma were 77.8%, 66.7% and 55.5%, respectively. The specificity for excluding any neoplasia was 91.7% for FIT, 74% for gFOBT and 94.5% for a combination, whereas for excluding only carcinomas they were 84%, 73.4% and 93.6%. Of the 69 with normal colonoscopic findings, FOBT was positive in 4.3%, 23.2 % and 2.9% for FIT, gFOBT, or combination of tests respectively. Conclusion: FIT is the recommended method if we are to dispense with dietary restriction in our patients because of its relatively low-false positivity and better sensitivity and specificity rates.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 47 条
  • [21] Colorectal cancer screening in asymptomatic adults: Comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests
    Cheng, TI
    Wong, JM
    Hong, CF
    Cheng, SH
    Chen, TJ
    Shieh, MJ
    Lin, YM
    Tso, CY
    Huang, AT
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2002, 101 (10) : 685 - 690
  • [22] Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: The patient perspective
    Deutekom, Marije
    van Rossum, Leo G. M.
    van Rijn, Anne F.
    Laheij, Robert J. F.
    Fockens, Paul
    Bossuyt, Patrick M. M.
    Dekker, Evelien
    Jansen, Jan B. M. J.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (11) : 1345 - 1349
  • [23] The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials
    Gruner, Laura F.
    Amitay, Efrat L.
    Heisser, Thomas
    Guo, Feng
    Niedermaier, Tobias
    Gies, Anton
    Hoffmeister, Michael
    Brenner, Hermann
    CANCERS, 2021, 13 (07)
  • [24] Aspirin Users Attending for NHS Bowel Cancer Screening Have Less Colorectal Neoplasia: Chemoprevention or False-Positive Faecal Occult Blood Testing?
    Lee, Thomas J. W.
    Hull, Mark A.
    Rajasekhar, Praveen T.
    Clifford, Gayle M.
    Ritchie, Mary
    James, Peter
    McNally, Richard J. Q.
    Rutter, Matthew D.
    Rees, Colin J.
    DIGESTION, 2012, 85 (04) : 278 - 281
  • [25] Offering Annual Fecal Occult Blood Tests at Annual Flu Shot Clinics Increases Colorectal Cancer Screening Rates
    Potter, Michael B.
    Hudes, Esther S.
    McPhee, Stepben J.
    Walsh, Judith M. E.
    ANNALS OF FAMILY MEDICINE, 2009, 7 (01) : 17 - 23
  • [26] Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB)
    Syrjaenen, Kari
    Eskelinen, Maaret
    Meklin, Jannica
    Hendolin, Panu
    Eskelinen, Matti
    Suovaniemi, Osmo
    ANTICANCER RESEARCH, 2024, 44 (04) : 1513 - 1523
  • [27] Colorectal cancer screening; colonoscopy and biopsy results in people undergoing colonoscopy due to positive fecal occult blood test
    Yucel, Metin
    Demirpolat, Muhammed Taha
    Yildirak, Muhammed Kadir
    TURKISH JOURNAL OF SURGERY, 2024, 40 (01) : 59 - 64
  • [28] FECAL OCCULT BLOOD SCREENING FOR COLORECTAL NEOPLASIA - A RANDOMIZED TRIAL OF 3 DAYS OR 6 DAYS OF TESTS
    THOMAS, WM
    PYE, G
    HARDCASTLE, JD
    MANGHAM, CM
    BRITISH JOURNAL OF SURGERY, 1990, 77 (03) : 277 - 279
  • [29] Clinical Factors Associated with Adherence to the Follow-Up Examination after Positive Fecal Occult Blood Test in National Colorectal Cancer Screening
    Kim, Byung Chang
    Kang, Minjoo
    Park, Eunjung
    Shim, Jeong-Im
    Kang, Shinhee
    Lee, Jessie
    Tchoe, Ha Jin
    Kong, Kyeong Ae
    Kim, Duk Hwan
    Kim, Yu Jin
    Choi, Kui Son
    Moon, Chang Mo
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [30] Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening
    Ibanez-Sanz, Gemma
    Garcia, Montse
    Rodriguez-Moranta, Francisco
    Binefa, Gemma
    Gomez-Matas, Javier
    Domenech, Xenia
    Vidal, Carmen
    Soriano, Antonio
    Moreno, Victor
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (10) : 1249 - 1254